The North America Orthokeratology Lens Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Myopia is becoming more common worldwide, which is the main driver fueling the market's expansion. There is an increase in the number of senior people and a rising in the number of people of all ages developing eye diseases from the prolonged laptop and computer use. Recently, in order to assess the state of the ortho-K for contact lens wearers, researchers distributed a national survey to eyecare professionals who treat ortho-K patients. They discovered that although ortho-K lenses presently only account for a small portion of the lenses used by patients, the industry is growing and appears to be poised for rapid expansion in the coming years.
By altering the cornea's curvature, orthokeratology corrects refractive problems without the use of surgery and enhances the ability to see objects clearly. Governments in both developed, as well as developing countries, have made large investments in healthcare facilities over the years, which are expected to boost this market's expansion over the course of the forecast period.
The aging population is continuously growing and the demand for Corneal Refractive Therapy (CRT) & Vision Shaping Treatment diagnostic and treatment (VST) is also rising. As the ophthalmology sector has expanded quickly in the United States and Canada, there has been an increase in the demand for orthokeratology in North America. Government agencies in the region have also provided sizeable payments for eye treatments, spurring market expansion.
The US market dominated the North America Orthokeratology Lens Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $229.4 Million by 2028. The Canada market is poised to grow at a CAGR of 8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.1% during (2022 - 2028).
Based on Product Type, the market is segmented into Overnight Ortho-K lenses and Day-time Ortho- K lenses. Based on Indication, the market is segmented into Myopia, Presbyopia Hypermetropia and Astigmatism. Based on Distribution Channel, the market is segmented into Ophthalmology Clinics, Optometry Clinics, Hospitals, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Orthokeratology Lens Market is Estimated to reach $898.3 Million by 2028, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Bausch Health Companies, Inc., The Cooper Companies, Inc., Euclid Systems Corporation, Alpha Corporation, Inc. (Menicon Co., Ltd.), Brighten Optix Corporation, TruForm Optics, Inc., Art Optical Contact Lens, Inc., and MiracLens, LLC.
By Product Type
By Indication
By Distribution Channel
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 